These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3412115)

  • 1. Membrane lipid alteration: effect on cellular uptake of mitoxantrone.
    Burns CP; Haugstad BN; Mossman CJ; North JA; Ingraham LM
    Lipids; 1988 May; 23(5):393-7. PubMed ID: 3412115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
    Petersen ES; Kelley EE; Modest EJ; Burns CP
    Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the fatty acid composition of L1210 leukemia subcellular organelles.
    Burns CP; North JA; Mossman CJ; Ingraham LM
    Lipids; 1988 Jun; 23(6):615-8. PubMed ID: 3172992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular distribution of doxorubicin: comparison of fatty acid-modified and unmodified cells.
    Burns CP; North JA; Petersen ES; Ingraham LM
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):455-60. PubMed ID: 3420109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
    Wagner BA; Buettner GR; Burns CP
    Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells.
    Guffy MM; North JA; Burns CP
    Cancer Res; 1984 May; 44(5):1863-6. PubMed ID: 6231987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin transport and sensitivity in fatty acid-modified leukemia cells.
    Burns CP; North JA
    Biochim Biophys Acta; 1986 Aug; 888(1):10-7. PubMed ID: 3741885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane transport of mitoxantrone by L1210 leukemia cells.
    Burns CP; Haugstad BN; North JA
    Biochem Pharmacol; 1987 Mar; 36(6):857-60. PubMed ID: 3566786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature dependence and effect of membrane lipid alteration on melphalan transport in L1210 murine leukemia cells.
    Burns CP; Dudley DT
    Biochem Pharmacol; 1982 Jun; 31(11):2116-9. PubMed ID: 7115429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cellular fatty acid alteration on hyperthermic sensitivity in cultured L1210 murine leukemia cells.
    Guffy MM; Rosenberger JA; Simon I; Burns CP
    Cancer Res; 1982 Sep; 42(9):3625-30. PubMed ID: 6213296
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells.
    Burns CP; Luttenegger DG; Dudley DT; Buettner GR; Spector AA
    Cancer Res; 1979 May; 39(5):1726-32. PubMed ID: 218733
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of rate of heating on thermosensitivity of L1210 leukemia: membrane lipids and Mr 70,000 heat shock protein.
    Burns CP; Lambert BJ; Haugstad BN; Guffy MM
    Cancer Res; 1986 Apr; 46(4 Pt 1):1882-7. PubMed ID: 3948170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity in modification of the fatty acid composition of normal mouse tissues and membranes in vivo.
    Burns CP; Rosenberger JA; Luttenegger DG
    Ann Nutr Metab; 1983; 27(4):268-77. PubMed ID: 6881913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative alpha-tocopherol deficiency in cultured cells: free radical-mediated lipid peroxidation, lipid oxidizability, and cellular polyunsaturated fatty acid content.
    Kelley EE; Buettner GR; Burns CP
    Arch Biochem Biophys; 1995 May; 319(1):102-9. PubMed ID: 7771773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid metabolism in L1210 murine leukemia cells: differences in modification of fatty acids incorporated into various lipids.
    Burns CP; Wei SP; Spector AA
    Lipids; 1978 Oct; 13(10):666-72. PubMed ID: 723478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane fatty acid modification in tumor cells: a potential therapeutic adjunct.
    Burns CP; Spector AA
    Lipids; 1987 Mar; 22(3):178-84. PubMed ID: 3573998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of the aliphatic chains of Clostridium acetobutylicum by exogenous fatty acids: regulation of phospholipid and glycolipid composition.
    Johnston NC; Goldfine H
    J Bacteriol; 1992 Mar; 174(6):1848-53. PubMed ID: 1548233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron spin resonance studies on intact cells and isolated lipid droplets from fatty acid-modified L1210 murine leukemia.
    Simon I; Burns CP; Spector AA
    Cancer Res; 1982 Jul; 42(7):2715-21. PubMed ID: 6282447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of membrane phospholipid fatty acyl composition in a leukemic T cell line: effects on receptor mediated intracellular Ca2+ increase.
    Chow SC; Sisfontes L; Jondal M; Björkhem I
    Biochim Biophys Acta; 1991 May; 1092(3):358-66. PubMed ID: 1646642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid utilization by L1210 murine leukemia cells.
    Burns CP; Wei SP; Welshman IR; Wiebe DA; Spector AA
    Cancer Res; 1977 Jul; 37(7 Pt 1):1991-7. PubMed ID: 558821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.